qPCR Congress 2010 15th & 16th November
Monday 15th November 2010 to Tuesday 16th November 2010 London, UK, - Ł650.00/person
Over two days, the event will attract over 120 senior-level decision makers working in qPCR from the UK, Europe and US. This conference explores effective strategies, technologies and applications of qPCR in accelerating drug discovery and development of clinical diagnostics
The event provides a forum for practitioners and prominent innovators to learn more about key solutions being provided to their industry, network with their peers, and address key industry concerns through a series of cutting edge conference presentations in a professional yet relaxed environment, during a 2 day conference programme
Day 1
Stream 1: qPCR in Diagnostics and Molecular Markers as well as Novel Technical Approaches
- Successful Gene Expression Analysis using real-time PCR
- Profiling technologies: multivariate and multiway expression profiling, temporal expression profiling and spatiotemporal maps
- Other technologies: High resolution melt, Immuno PCR, Methylation sensitive PCR, SNP analysis, microRNA detection and Multiplex technologies
- Development of clinical diagnostics and clinical Development – use in therapeutic areas such as cancer and infectious diseases
Stream 2: Bioinformatics and Data Management
- Bioinformatics
- Data management: software applications, data mining, data visualization, biostatistics, multivariate statistics
Day 2
Stream 1: qPCR in Drug Discovery and Development
- Assay optimisation and validation strategies
- New applications of qPCR- High throughput applications, Real-time RT-PCR arrays and Digital PCR
- The discovery of Biomarkers: Disease markers, Tissue specific markers, Cancer markers, Stem cells, Differentiation markers and Cancer stem cells
- The potential and use of qPCR reagents and instrumentation
Stream 2: Next Generation Sequencing – High Throughput Sequencing Platforms
|
 |
 |
 |
| Hear insights and views from our leading line up of industry experts: |
 |
|
|
Prof. Claudio Orlando, Professor, Clinical Biochemistry Unit, Department of Clinical Physiopathology, University of Florence
|
 |
|
|
Dr. Neven Zoric, CEO, TATAA Biocenter
|
 |
|
|
Susanne Heinsohn, University Hospital Hamburg-Eppendorf, Clinic for Hematology and Oncology, Germany
|
 |
|
|
Afif Abdel Nour, Research Scientist, Molecular Biotechnology, Institut Polytechnique LaSalle Beauvais
|
 |
|
|
Dr. Raffaele Di Francia, Lab of Molecular Hematology, Institute of Tumors G. Pascale
|
 |
|
|
Dr. Mathias Schmidt, Associate Principal, Strategic Planning and Business Support, Nycomed GmbH
|
 |
|
|
Dr Veronika Okršlar, Biopharmaceuticals, Cell and Molecular Biology, Lek Pharmaceuticals d.d.a. Sandoz Company
|
 |
|
|
Sami Hokkanen, Senior Biostatician, Research & Translational Statistics, Biostatistics & Support Functions, R&D, Orion Pharma
|
 |
|
|
Dr. Benaissa El-Moualij, Center of Immunology, Institute of Pathology, University of Liege
|
 |
|
|
Paul E. Kroeger, Senior Group Leader GPRD, Neuroscience & Pain Discovery, Abbott Laboratories
|
 |
|
|
Dr Gustavo H. Kijak, Chief of Section Host Genetics, Military HIV Program, Henry M Jackson Foundation
|
 |
|
|
Dr. Jan Kristek, Director and Head of Immunological Department, Karlovarske Imunologicke Centrum
|
 |
|
|
Dr Jo Woods, Senior Research Scientist, MedImmune
|
 |
|
|
Dr Jeroen Aerssens, Head Translational Genomics & Genetics, European Discovery Capabilities, Tibotec BVBA - Johnson & Johnson
|
 |
|
|
Dr. Hansjoerg Keller, Senior Research Investigator, Novartis
|
 |
|
|
Dr. Rolf Studer, Senior Lab Head, Actelion
|
 |
|
|
Andreas Weinhausel, Senior Scientist, Molecular Diagnostics, Austrian Research Centers ARC
|
 |
|
|
Dr Viktor Lakics, Senior Research Scientist - Neurodegeneration DHT, Eli Lilly
|
 |
|
|
Dr. Nana Jacobsen, Senior Scientist, Exiqon
|
 |
|
|
Dr Ales Trichopad, Co Founder and CTO, Labonnet
|
 |
|
|
Dr. Ian Kavanagh, Research and Develoment Manager, Thermo Scientific Genomics
|
 |
|
|
Dr. Emiliano Toso Head of the Molecular Biology Laboratory RBM Merk Serono
|
 |
|
|
Senior Representative, Qiagen
|
 |
|
|
Prof. Michael Kubista, Head Laboratoř genové exprese, Biotechnologický ústav AV ČR
|
 |
|
|
Dr Dan Turner, Head of Sequencing Technology, Wellcome Trust Sanger Institute
|
 |
|
|
Dr. Victor Turcanu, Lecturer in Paediatric Allergy, Division of Asthma, Allergy and Lung Biology, King's College London
|
 |
|
|
Patricia McLoughlin, Head of Genomics, F. Hoffmann-La Roche Ltd
|
 |
|
|
Dr Olivier Grenet, Group Head Genome Biology, Investigative Toxicology, Translational Sciences, Novartis Pharma
|
 |
|
|
Dr Andrej-Nikolai Speiss, Department of Andrology, University Hospital Hamburg-Eppendorf
|
 |
|
|
Dr Roman Artymyshyn, Principal Scientist, Target Discovery and Assessment, Lundbeck Research
|
 |
|
|
Jean-Luc Henrioul, Commercial and Business Development Director, BioXpr
|
 |
|
|
Dr Marco Tomasetti, Department of Molecular Pathology and Innovative Therapies, Polytechnic University of Marche, Italy
|
 |
|
|
Ralf Mauritz, Director, R&D, Roche Diagnostics GmbH
|
 |
|
|
Dr Chaminda Salgado, Head of PCR Services, Pharmaceutical Analysis, NDA Analytics
|
 |
|
|
Dr Natasha Paul, Senior Staff Scientist, TriLink Biotechnologies
|
 |
|
|
Dr. Jan M. Ruijter, Department of Anatomy and Embryology, Academic Medical Centre, Amsterdam
|
 |
|
|
Mirco Castoldi, Postdoctoral Fellow, Hentze Group, EMBL Heidelberg, Germany
|
 |
|
|
Dr. Thorsten Traeger, Project Manager, R&D, Qiagen
|
 |
|
|
Stig Ove Hjelmevoll, Scientist, Department of Microbiology and Infection Control, University Hospital of North Norway
|
 |
|
 |
 |
 |
|
|
|